Search

Search Results

• Dare voce ai pazienti nella ricerca sulle malattie rare e sui famaci orfani / Giving patients a voice in the rare diseases and orphan drugs research

  Elena Mancini, Roberta Martina Zagarella

  25-40

  23-03-2018

  https://doi.org/10.4081/mem.2018.526

  859

  PDF (Italian): 14

• Ethical principles in prescribing drugs to elderly patients

  F. Cavazzuti, R. Nardi, C. D'Anastasio

  637-665

  31-08-1994

  https://doi.org/10.4081/mem.1994.1006

  194

  PDF (Italian): 0

• Diritto alla salute, equità e governance delle malattie neglette e della povertà / Right to health, equity and governance of neglected diseases and poverty

  Elena Mancini

  477-493

  06-10-2016

  https://doi.org/10.4081/mem.2016.444

  886

  PDF (Italian): 22

• Clinical and ethical use of induced pluripotent stem cells / Uso clinico ed etico delle cellule pluripotenti indotte

  Jaime Millás-Mur

  291-305

  30-07-2018

  https://doi.org/10.4081/mem.2018.540

  1067

  PDF (Italian): 7

• La figura del biostatistico nei Comitati Etici (CE). Linee guida per il ruolo del biostatistico e per l'attività del biostatistico nella revisione dei protocolli degli studi proposti al parere dei CE / The figure of biostatistician for Ethics Committees (ECs). Guidelines for the role of biostatistician and for the activity of biostatistician in the review of research protocols proposed for ECs

  Bruno Mario Cesana, Elio Mario Briganzoli

  567-588

  23-11-2016

  https://doi.org/10.4081/mem.2016.454

  859

  PDF (Italian): 6

• L'autosperimentazione nelle malattie rare: analisi dei profili etici e indicazioni per una possibile governance / The self-experimentation on rare diseases: analysis of ethical profiles and instructions for a possible governance

  Elena Mancini

  45-61

  15-03-2017

  https://doi.org/10.4081/mem.2017.475

  914

  PDF (Italian): 5

• Una pillola per diventare più buoni? Il dibattito sul "moral bioenhancement" / A pill to become better people? The debate on "moral bioenhancement"

  Francesco Paolo Adorno

  131-153

  21-09-2016

  https://doi.org/10.4081/mem.2016.431

  996

  PDF (Italian): 6

• Oltre il visibile Le nanotecnologie e la nanomedicina: definizioni e problematiche bioetiche

  Antonio G. Spagnolo, Viviana Daloiso

  30-06-2008

  https://doi.org/10.4081/mem.2008.280

  778

  PDF (Italian): 1

• Il dibattito in Bioetica - I nuovi farmaci per l'HCV: una possibile "lezione metodologica" / The debate in Bioethics. The new drugs for HCV: a possible "methodological lesson"

  Dario Sacchini

  533-537

  11-10-2017

  https://doi.org/10.4081/mem.2017.505

  871

  PDF (Italian): 20

• "Unsustainable drugs" and intergenerational healthcare justice

  Pietro Refolo, Dario Sacchini, Filippo Rumi, Americo Cicchetti, Antonio G. Spagnolo

  411-422

  20-12-2019

  https://doi.org/10.4081/mem.2019.596

  762

  PDF (Italian): 27

• "Good Clinical Practice". The European Community guidelines for trials on medicinal products

  Antonio G. Spagnolo

  201-227

  30-06-1991

  https://doi.org/10.4081/mem.1991.1141

  205

  PDF (Italian): 0

• Specific receptor drugs in the therapeutic strategy of opioid addiction

  Paolo Preziosi

  15-10-2024

  https://doi.org/10.4081/mem.1981.1548

  105

  PDF: 2

• The psychological outcome and ethical and assistance implications for heart transplant subjects

  Antonio Puca

  87-97

  28-02-1992

  https://doi.org/10.4081/mem.1992.1116

  209

  PDF (Italian): 0

• Clinical trials of drugs: Current state of the regulatory problem and proposals for reform

  Adriano Bompiani

  14-10-2024

  https://doi.org/10.4081/mem.1982.1529

  93

  PDF: 0

• Ulipristal acetate. An emergency contraceptive?

  Justo Aznar, Julio Tudela

  30-04-2011

  https://doi.org/10.4081/mem.2011.170

  833

  PDF (Italian): 3

• Elderly person and medication

  L. Antico, A. Greco, A. Cocchi, G. Franceschini, P.U. Carbonin

  26-09-2024

  https://doi.org/10.4081/mem.1985.1431

  84

  PDF: 0

• The availability of the body

  Roberto Mordacci

  491-509

  30-06-1994

  https://doi.org/10.4081/mem.1994.1017

  141

  PDF (Italian): 0

• L'utilizzo del placebo secondo l'ultima versione della Dichiarazione di Helsinki. Dibattito fra due posizioni etiche

  Fabrizio Liborio, Pablo Requena Meana

  28-02-2015

  https://doi.org/10.4081/mem.2015.33

  1343

  PDF (Italian): 6

• Newborn with Ohtahara Syndrome and absence of respiratory trigger: ethical issues in the NICU

  Barbara Corsano, Dario Sacchini, Giovanni Vento, Simonetta Costa, Alice Esposito, Domenica Battaglia, Michela Quintiliani, Antonio G. Spagnolo

  69-82

  11-04-2023

  https://doi.org/10.4081/mem.2023.1229

  687

  PDF (Italian): 18

• Pain Therapy.

  Giovanni Del Missier, Laura Colautti

  255-260

  30-04-2002

  https://doi.org/10.4081/mem.2002.700

  216

  PDF (Italian): 1

• The training of the specialized physician within the European prospective

  Francesco Antonio Manzoli

  253-263

  30-04-1990

  https://doi.org/10.4081/mem.1990.1181

  167

  PDF (Italian): 0

• Strategies for clinical research on AIDS and HIV infection

  Paolo Cattorini, Roberto Mordacci

  819-839

  31-12-1991

  https://doi.org/10.4081/mem.1991.1123

  175

  PDF (Italian): 0

• The fragility of medical communication: the miniseries Dopesick in the clash between narratives on the opioid epidemic

  Paolo Braga

  561-581

  19-12-2025

  https://doi.org/10.4081/mem.2025.1662

  277

  PDF (Italian): 1

• Too sick for drugs. Too knotty for principles. Scientific research, ethics and cinema

  Paolo Marino Cattorini

  141-164

  30-06-2019

  https://doi.org/10.4081/mem.2019.579

  629

  PDF: 10